Page last updated: 2024-10-16

gamma-aminobutyric acid and Granulocytic Leukemia, Chronic

gamma-aminobutyric acid has been researched along with Granulocytic Leukemia, Chronic in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"Chronic myelogenous leukemia is caused by the Bcr-Abl hybrid gene that encodes the p210Bcr-Abl chimeric oncoprotein."1.34Novel compounds with antiproliferative activity against imatinib-resistant cell lines. ( Austin, DJ; Deisseroth, A; Kufe, D; Lerma, EI; Melo, JV; Nguyen, VA; Tipping, A; Wang, T, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerma, EI1
Nguyen, VA1
Wang, T1
Tipping, A1
Melo, JV1
Kufe, D1
Austin, DJ1
Deisseroth, A1

Other Studies

1 other study available for gamma-aminobutyric acid and Granulocytic Leukemia, Chronic

ArticleYear
Novel compounds with antiproliferative activity against imatinib-resistant cell lines.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:2

    Topics: Alkynes; Benzamides; Cell Proliferation; Drug Resistance, Neoplasm; Furans; Fusion Proteins, bcr-abl

2007